Facilitated By

San Antonio Medical Foundation

Evaluation of anti-bacterial effects of novel formulations that target an essential metabolic pathway of the agent of Lyme disease.

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Janakiram Seshu
Funded by
UTSA VPR Office
Research Start Date
Status
Active

Basic Research

Collaborative Project
Basic Research
Drug Discovery
Infectious Disease